Hydralazine pdr/inj 20mg amp/BOX-5

General description:
Hydralazine powder for injection, once reconstituted solution for slow IV injection. Hydralazine 20 mg powder for injection, box of 5 ampoules.

Technical specifications:
Each 2ml ampoule contains 20 mg Hydralazine Hydrochloride.

Therapeutic class:
Hydralazine is a Phthalazine derivative.

Indications
Treatment of hypertensive emergencies, particularly those associated with pre-eclampsia and toxaemia of pregnancy.

Dosage, Instructions for use
Refer to the guidelines below:
WHO Model Formulary 2008

Shelf life:
5 years (60 months).

Storage and transportation:
The product must be transported between +15 °C to + 25°C unless specified otherwise.

Dispensing instructions
Dispense in original container. Do not repack. Please note the box does not contain solvent for reconstitution. The content of the ampoule should be reconstituted by dissolving in 1 ml water for injection (S1543805 WFI 10 ml /BOX-50 or S1543803 WFI 5 ml/BOX-50). This should then further diluted with 10 ml of Sodium Chloride injection 0.9% (S1564320 Sod.chloride inj.0.9% 10ml/BOX-5) and be administered by slow intravenous injection. The injection must be given immediately and any reminder discarded.

Component of a KIT
Yes